ZEPP — Stock Film
STOCK FILMSCENE 1/10ZEPP · $4.58
Stock Expert AI presents
ZEPP
Zepp Health Corporation
~5 min film100% real numbersplain English
WHAT DOES THIS COMPANY DO?
Zepp Health Corporation. What it actually does.

Develops and manufactures smart wearable devices such as bands and watches. Offers health and fitness tracking through mobile applications. Now — the numbers.

on the stock market since 2018
763 employees
$65.6M market value
WHERE DOES THE MONEY COME FROM?
74%Manufactured Product, Other
Manufactured Product, OtherProducts 26%
74% of all revenue comes from a single line: Manufactured Product, Other.

That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.

Revenue last year:
$271.1M
The loss that same year:
$41.9M
For every $1 it earns, the company spends $1.2.

The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.

In the vault right now:
$117.9M
DEBT: $238.1M
At this pace, that money lasts about 2.8 years.

At this burn rate the cash pile isn’t the pressing question — for now, time is on the company’s side.

INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
23
very weak

Clearly below the class average.

FINANCIAL STRENGTH
9
very weak

Clearly below the class average.

VALUATION
52
average

The price isn’t cheap next to earnings — that’s why this grade sits in the middle.

GROWTH
69
strong

Clearly above the class average — a step short of the very top.

PRICE MOMENTUM
15
very weak

Clearly below the class average.

WORTH WATCHING

Financial Strength: The cash-and-debt balance is thin; the buffer for hard times is slim.

Price Momentum: The stock has lagged the market in recent months; investor interest is weak right now.

THE FIVE-YEAR JOURNEY
A big climb, then a hard fall.

An investor who bought at the very peak is down 93% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.

1
THE BRIGHT SIDE · 1/2
Sales keep climbing

Over the last 4 years, sales grew about 17% a year on average.

2
THE BRIGHT SIDE · 2/2
The product is selling

Sales run at $271.1M a year. A small number, but proof the product has real buyers.

1
THE RISKS · 1/3
Running at a loss

A loss of $41.9M against $271.1M in annual sales.

2
THE RISKS · 2/3
A thin financial cushion

The balance sheet offers little cushion against a rough stretch. Report-card grade: 9/100.

3
THE RISKS · 3/3
The stock has lost its spark

Buyers haven’t stepped back in yet; the price hasn’t found its footing. Report-card grade: 15/100. For a turnaround signal, the stock first needs to close the gap with the market.

FINALE · THE GRADE
F
26 / 100 · MoonshotScore

On our five-subject report card, ZEPP sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”

The takeaway: ZEPP is a high-risk stock — not yet profitable, and its future rides on its product catching on.

The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.

Analysts’ average target sits above today’s price, yet the valuation grade (52/100) says the stock isn’t cheap.

What would you like to do next?
Open the stock page →

Not covered, because the filings we hold do not carry it: earnings execution.

This was a film — not investment advice.
Data: FMP & company filings
Sep 11, 2026 · stockexpertai.com · Stock Film